Abstract:Parkinson's disease (PD) is a common age-related neurodegenerative disorder characterized by the aggregation of α-Synuclein (αSYN) building up intraneuronal inclusions termed Lewy pathology. Mounting evidence suggests that neuron-released αSYN aggregates could be central to microglial activation, which in turn mounts and orchestrates neuroinflammatory processes potentially harmful to neurons. Therefore, understanding the mechanisms that drive microglial cell activation, polarization and function in PD might have important therapeutic implications. Here, using primary microglia, we investigated the inflammatory potential of pure αSYN fibrils derived from PD patients. We further explored and characterized microglial cell responses to a chronic-type inflammatory stimulation combining PD patient-derived αSYN fibrils (F PD ), Tumor necrosis factor-α (TNFα) and prostaglandin E 2 (PGE 2 ) (TPF PD ). We showed that F PD hold stronger inflammatory potency than pure αSYN fibrils generated de novo. When combined with TNFα and PGE 2 , F PD polarizes microglia toward a particular functional phenotype departing from F PD -treated cells and featuring lower inflammatory cytokine and higher glutamate release. Whereas metabolomic studies showed that TPF PD -exposed microglia were closely related to classically activated M1 proinflammatory cells, notably with similar tricarboxylic acid cycle disruption, transcriptomic analysis revealed that TPF PD -activated microglia assume a unique molecular signature highlighting upregulation of genes involved in glutathione and iron metabolisms. In particular, TPF PD -specific upregulation of Slc7a11 (which encodes the cystine-glutamate antiporter xCT) was consistent with the increased glutamate response and cytotoxic activity of these cells toward midbrain dopaminergic neurons in vitro. Together, these data further extend the structure–pathological relationship of αSYN fibrillar polymorphs to their innate immune properties and demonstrate that PD-derived αSYN fibrils, TNFα and PGE 2 act in concert to drive microglial cell activation toward a specific and highly neurotoxic chronic-type inflammatory phenotype characterized by robust glutamate release and iron retention.

Caspase-1 Causes Truncation and Aggregation of the Parkinson’s Disease-Associated Protein Α-Synuclein

C-terminal Truncation Exacerbates the Aggregation and Cytotoxicity of Α-Synuclein: A Vicious Cycle in Parkinson's Disease.

Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease

Α-Synuclein Disrupts Stress Signaling by Inhibiting Polo-Like Kinase Cdc5/Plk2

Templating of Monomeric Alpha-Synuclein Induces Inflammation and SNpc Dopamine Neuron Death in a Genetic Mouse Model of Synucleinopathy.

Proaggregant Nuclear Factor(s) Trigger Rapid Formation of Α-Synuclein Aggregates in Apoptotic Neurons

-Synuclein phase separation and amyloid aggregation are modulated by C-terminal truncations

Parkinson's disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype

Asparagine endopeptidase cleaves synaptojanin 1 and triggers synaptic dysfunction in Parkinson's disease

Extracellular Α-Synuclein--a Possible Initiator of Inflammation in Parkinson's Disease.

Α‐synuclein Stimulation of Monoamine Oxidase‐b and Legumain Protease Mediates the Pathology of Parkinson's Disease

Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity

C-terminal truncation of α -synuclein alters DNA structure from extension to compaction

Aggregation States of α-Synuclein and Its Involvement in Parkinson’s Disease

Exploring the Impact of Physiological C-Terminal Truncation on Α-Synuclein Conformations to Unveil Mechanisms Regulating Pathological Aggregation

Distinct Effects of Familial Parkinson's Disease-Associated Mutations on Α-Synuclein Phase Separation and Amyloid Aggregation.

Modeling Parkinson's disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines

α-synuclein regulates Cyclin D1 to promote abnormal initiation of the cell cycle and induce apoptosis in dopamine neurons

α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease

Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease

Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology